Molecular targets are identified through a combination of genomic, proteomic, and bioinformatics approaches. Techniques such as next-generation sequencing (NGS), mass spectrometry, and computational biology are used to analyze cancer cells and identify mutations, overexpressed proteins, and other molecular abnormalities.
